Journal of Cardiovascular Pharmacology

MAY 2, 2024

Patient characteristics and clinical outcomes were collected via electronic medical record system. The primary outcome was major adverse cardiac and cerebrovascular event (MACCE), namely a composite of death from cardiovascular causes, myocardial infarction (MI), stroke, stent thrombosis within 12 month.

Outcomes 40

Outcomes Myocardial Infarction Thrombosis Academic 40

Circulation: Cardiovascular Interventions

MARCH 30, 2025

However, whether the addition of OCT to angiography to guide percutaneous coronary intervention (PCI) of complex lesions affects clinical outcomes is debated.Methods:A systematic search for randomized controlled trials (RCTs) was conducted using PubMed, Scopus, and Cochrane databases through September 2024.

Thrombosis 40

Thrombosis Myocardial Infarction Stent Stents 40

Open Heart

NOVEMBER 28, 2023

Eligible were all aetiological studies evaluating risk of cardiovascular outcomes after exposure to common RTIs within any follow-up duration. COVID-19 likely increases relative risk (RR (95% CI)) of myocardial infarction (3.3 (1.0 to 44.9)) and deep venous thrombosis (7.8 (4.3 to 11.0)), stroke (3.5 (1.2 95% CI 1.8

Myocardial Infarction 52

Myocardial Infarction COVID-19 Cardiovascular Disease Thrombosis 52

Open Heart

JUNE 18, 2024

The LEADERS FREE III (LF III) trial investigated clinical outcomes after PCI with the next-generation cobalt-chromium thin-strut polymer-free biolimus-coated stent (CoCr-BCS) in HBR patients. The primary safety endpoint was the composite of cardiac death (CD), myocardial infarction(MI) or definite/probable stent thrombosis (ST).

Stent 40

Stent Stents Outcomes Myocardial Infarction 40

Cardiology Update

FEBRUARY 14, 2024

In the early years of percutaneous coronary intervention (PCI), studies indicated a heightened risk of major adverse cardiac events (MACE) in patients with reduced left ventricular ejection fraction (LVEF), involving outcomes such as death, Q-wave myocardial infarction (MI), stent thrombosis, and repeat revascularization.

Myocardial Infarction 52

Myocardial Infarction Coronary Artery Disease Thrombosis Research 52

Open Heart

DECEMBER 29, 2022

Methods A search was conducted on five databases for randomised controlled trials (RCTs) conducted between 1 January 2000 and 17 July 2022, which included an ADP-specific platelet function assays and P2Y 12 antagonists as part of dual antiplatelet therapy (DAPT) and have reported the efficacy and/or safety outcomes.

Myocardial Infarction 52

Myocardial Infarction Thrombosis Stent Stents 52

Open Heart

APRIL 15, 2022

Efficacy outcomes included the major adverse cardiovascular events outcome and safety outcomes included minor and major bleedings. We performed a frequentist network meta-analysis. Results Nine studies (n=35 441 patients) were included in the systematic review.

Myocardial Infarction 52

Myocardial Infarction Thrombosis Stent Stents 52

Open Heart

OCTOBER 26, 2022

MEDLINE, EMBASE and Web of Science were searched from inception through 5 January 2022 for RCTs comparing the clinical outcomes of BVS versus DES. Secondary outcomes were patient-oriented composite endpoint (combining all-death, all-MI and all-revascularisation), its individual components and those of TLF.

Stent 52

Stent Stents Coronary Artery Disease Myocardial Infarction 52

Stroke Journal

JANUARY 30, 2025

Migraine with aura(MwA) is associated with an increased risk of stroke and adverse vascular outcomes compared to those with migraine without aura (MwoA). Patients with any adverse vascular outcomes before the index ECG were excluded. The prevalences of all vascular outcomes are summarized in Table 1. p < 001).

Atrial Fibrillation 40

Atrial Fibrillation Outcomes Coronary Artery Disease Myocardial Infarction 40

Circulation

OCTOBER 24, 2023

The primary endpoint was the net clinical benefit as a composite of all-cause death, myocardial infarction, definite or probable stent thrombosis, stroke, and major bleeding at 1 year after the index procedure in the intention-to-treat population. 0.80];P<0.001 for noninferiority;P=0.002 for superiority).

Stent 40

Stent Stents Myocardial Infarction Thrombosis 40

Stroke Journal

FEBRUARY 1, 2024

In severe OHSS, increases in capillary permeability can result in hemoconcentration and hypercoagulability leading to thrombotic events, including stroke and cerebral venous thrombosis. The low rate of outcome events after OHSS seen in each of our population-level analyses increases the reliability of these study results.

Thrombosis 40

Thrombosis Inpatient Embolism Myocardial Infarction 40

Coronary Artery Disease Journal

AUGUST 22, 2024

Other outcomes were comparable in both groups. Major ischemic outcomes were similar. Data were extracted from published reports and quality assessment was performed per Cochrane recommendations. Major bleeding [hazard ratio 0.47; 95% confidence interval (CI), 0.37–0.61; 0.61; P < 0.001], NACE (hazard ratio 0.71; 95% CI, 0.56–0.90;

Myocardial Infarction 40

Myocardial Infarction Thrombosis Stent Stents 40

Journal of the American Heart Association

JANUARY 10, 2025

Bleeds were adjudicated using International Society on Thrombosis and Haemostasis criteria. Epistaxis events were less severe than nonepistaxis bleeds (International Society on Thrombosis and Haemostasis major: 3.2% Among 5247 patients with a bleeding event, 1008 (19.2%) had epistaxis and 4239 (80.8%) had nonepistaxis bleeding.

Atrial Fibrillation 40

Atrial Fibrillation Thrombosis Myocardial Infarction Hemorrhage 40

All About Cardiovascular System and Disorders

APRIL 21, 2024

Routine FFR measurement probably lead to more judicious use of stents and improved outcomes. They had lower rates of mortality or myocardial infarction. myocardial infarction rate and 3.2% Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. The lesions deferred on basis of FFR had only a 0.2%

Myocardial Infarction 52

Myocardial Infarction Stent Stents Coronary Artery Disease 52

Stroke: Vascular and Interventional Neurology

OCTOBER 2, 2023

Safety outcomes included rates of symptomatic intracranial hemorrhage, parenchymal hematoma type 2, petechial hemorrhage, and in‐stent thrombosis. Similarly, the rate of in‐stent thrombosis was not significantly different between the 2 groups (1.8% 4.98];P=0.589), or petechial hemorrhage (OR, 1.11 [95% CI, 0.38–3.28];P=0.836).

Hemorrhage 40

Hemorrhage Thrombosis Stent Stents 40

Dr. Smith's ECG Blog

NOVEMBER 15, 2013

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. It is important to recognize that coronary thrombosis is dynamic , with spontaneous opening and lysing of the thrombus in the infarct-related artery (we all have endogenous tPA and plasmin to lyse thrombi). Jernberg T, et al.

Chest Pain 52

Chest Pain Thrombosis Myocardial Infarction STEMI 52

Cardiology Update

APRIL 9, 2024

EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI). The percent change from baseline in fasting triglycerides (TG) at six months served as the primary outcome measure. In contrast, outcomes were better in patients with HF with reduced EF (HFrEF).

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Circulation

NOVEMBER 23, 2023

There was no difference in net adverse clinical outcomes and each component of coprimary cardiovascular end point. 3.30]) and subacute definite or probable stent thrombosis (0.58% and 0.17%; hazard ratio, 3.40 [95% CI, 1.26–9.23]) years; men, 76.6%; acute coronary syndrome, 75.0%). 1.45];Pnoninferiority=0.01).

Stent 40

Stent Stents Thrombosis Myocardial Infarction 40

Dr. Smith's ECG Blog

NOVEMBER 30, 2022

Such cases are classified as MINOCA (Myocardial Infarction with Non-Obstructed Coronary Arteries). MINOCA may be due to: coronary spasm, coronary microvascular dysfunction, plaque disruption, spontaneous coronary thrombosis/emboli , and coronary dissection. An angiogram is a "lumenogram;" most plaque is EXTRALUMINAL!!

Plaque 52

Plaque Chest Pain Thrombosis Stenosis 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Further research and attention to this area are crucial for improving patient outcomes and guiding clinical interventions in this challenging condition.MethodsICD‐10‐CM codes were used to query the National Inpatient Sample (NIS) for patients with AIS between 2010 and 2019.

Hemorrhage 40

Hemorrhage Aneurysm Cardiac Arrest Myocardial Infarction 40

DAIC

JANUARY 23, 2024

3 Patients with ASCVD are at a higher risk for major adverse cardiovascular events (MACE) including heart attack or myocardial infarction (MI), stroke, and cardiovascular (CV) death.4 Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. 4 In the U.S. 12 Importantly, colchicine, 0.5 N Engl J Med.

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

The mechanism is thought to be multifactorial due vasospasm, cerebral vasculitis, vascular thrombosis, cardioembolism from cocaine‐induced myocardial infarction or cardiomyopathy, and hypertensive surges [9]. Due to the scarcity of these events, the patient outcomes are unclear.

Ischemia 40

Ischemia Myocardial Infarction Thrombosis Stroke 40

Dr. Smith's ECG Blog

NOVEMBER 3, 2023

Yet this is rarely followed, and patient outcomes like this are the result once in a while. A New ST-segment elevation myocardial infarction equivalent pattern? The reappearance of de Winter's pattern caused by acute stent thrombosis: A case report. Am J Emerg Med. 2014;32:e5–e8. J Cardiol Cases. 2022;25(6):404-407.

Chest Pain 82

Chest Pain Cardiogenic Shock Ischemia Myocardial Infarction 82

Dr. Smith's ECG Blog

OCTOBER 3, 2018

Details cannot be shared here, but suffice it to say that inability to recognize acute occlusive myocardial infarction in the presence of ventricular paced rhythm contributed to a poor outcome. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analys is.

Chest Pain 52

Chest Pain Myocardial Infarction STEMI Ischemia 52

Dr. Smith's ECG Blog

NOVEMBER 4, 2022

New insights into the use of the 12-lead electrocardiogram for diagnosing acute myocardial infarction in the emergency department. Here is the abstract: Background Identification of ST elevation myocardial infarction (STEMI) is critical because early reperfusion can save myocardium and increase survival.

Ischemia 52

Ischemia STEMI Stenosis Chest Pain 52

Open Heart

MAY 12, 2023

Objective Antithrombotic therapy is essential for patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) because of the high risk of thrombosis, whereas a combination of antiplatelets and anticoagulants is associated with a high risk of bleeding.

Coronary Artery Disease 52

Coronary Artery Disease Atrial Fibrillation Myocardial Infarction Blood Pressure 52

Frontiers in Cardiovascular Medicine

NOVEMBER 28, 2024

We included major adverse cardiovascular events (MACE), myocardial infarction (MI), cardiac death and other outcome indicators. Relative ratio (RR) and 95% confidence interval (CI) were used for statistical analysis.ResultsA total of 5,173 subjects were included in 6 randomized control trials.

Stent 59

Stent Stents Coronary Artery Disease Myocardial Infarction 59

Frontiers in Cardiovascular Medicine

JANUARY 8, 2025

The primary focus is on the incidence of major adverse cardiovascular events (MACE), thrombosis, bleeding events, and adverse reactions. However, the effects of both treatments on efficacy outcomes, including MACE, myocardial infarction, angina, mortality, and thrombotic events, were similar.

Cerebrovascular Disease 52

Cerebrovascular Disease Cardiovascular Disease Myocardial Infarction Angina 52

Dr. Smith's ECG Blog

MARCH 8, 2025

Angiography was technically challenging as the patient was receiving CPR, but the cardiologist suspected acute stent thrombosis and initiated cangrelor, although no repeat angiography was able to be obtained. Was her outcome to be expected for ostial RCA OMI? Acute myocardial infarction triggered by emotional stress.

Cardiomyopathy 75

Cardiomyopathy Myocardial Infarction Defibrillator Bradycardia 75